JPMorgan Chase & Co’s Tevogen Bio Holdings TVGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.8K | Sell |
23,060
-50,441
| -69% | -$63.1K | ﹤0.01% | 5246 |
|
|
2025
Q1 | $79.4K | Buy |
73,501
+34,294
| +87% | +$37K | ﹤0.01% | 4845 |
|
|
2024
Q4 | $40.4K | Buy |
39,207
+16,695
| +74% | +$17.2K | ﹤0.01% | 5078 |
|
|
2024
Q3 | $8.29K | Buy |
22,512
+13,188
| +141% | +$4.86K | ﹤0.01% | 5351 |
|
|
2024
Q2 | $6.74K | Buy |
9,324
+9,294
| +30,980% | +$6.72K | ﹤0.01% | 5318 |
|
|
2024
Q1 | $112 | Buy |
+30
| New | +$112 | ﹤0.01% | 5875 |
|
|
2022
Q3 | – | Sell |
-50,000
| Closed | -$501K | – | 5870 |
|
|
2022
Q2 | $501K | Sell |
50,000
-141,590
| -74% | -$1.42M | ﹤0.01% | 3862 |
|
|
2022
Q1 | $1.91M | Buy |
+191,590
| New | +$1.91M | ﹤0.01% | 3211 |
|